Analystreport

Global Blood Therapeutics (NASDAQ: GBT) had its "outperform" rating re-affirmed by analysts at Wedbush.

Global Blood Therapeutics, Inc.  (GBT) 
NASDAQ:AMEX Investor Relations: ir.globalbloodtx.com